Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study

BACKGROUND: Recent studies indicate that survivin (BIRC5) is sensitive to the existence of previous ischemic heart disease, since it is activated in the process of tissue repair and angiogenesis. The aim of this study was to determine the potential of survivin (BIRC5) as a new cardiac biomarker in t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Biochem
Päätekijät: Marković, Danica, Jevtović-Stoimenov, Tatjana, Ćosić, Vladan, Stošić, Biljana, Dinić, Vesna, Marković-Živković, Bojana, Janković, Radmilo J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Sciendo 2018
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6294091/
https://ncbi.nlm.nih.gov/pubmed/30581346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jomb-2017-0046
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia